A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.

Clinical trial NCT01288079 · TERMINATED

Trial details

NCT number: NCT01288079
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2011-02-01
Primary completion: 2012-08-01
Enrollment: 145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.